These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12219469)

  • 21. [Epidemic increase in methicillin-resistant Staphylococcus aureus in Copenhagen].
    Westh H; Boye K; Bartels MD; Kristoffersen K; Bergen L; Havstreym J; Bagersted J; Petersen IS; Lester A; Lisby JG; Friis-Møller A; Knudsen JD; Slotsbjerg TD; Lundgren B
    Ugeskr Laeger; 2006 Feb; 168(7):671-3. PubMed ID: 16494803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals.
    MacKenzie FM; Bruce J; Struelens MJ; Goossens H; Mollison J; Gould IM;
    Clin Microbiol Infect; 2007 Mar; 13(3):269-76. PubMed ID: 17391381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An outbreak of methicillin resistant Staphylococcus aureus.
    Elshafie SS; Bernardo AR
    Saudi Med J; 2001 Sep; 22(9):815-6. PubMed ID: 11590462
    [No Abstract]   [Full Text] [Related]  

  • 24. MRSA: an infection control overview.
    Rayner D
    Nurs Stand; 2003 Jul 23-29; 17(45):47-53; quiz 54, 56. PubMed ID: 12929346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRSA: false economy may lead to dangerous practices.
    Edwards C
    Nurs Times; 2001 Sep 20-26; 97(38):54-6. PubMed ID: 11935859
    [No Abstract]   [Full Text] [Related]  

  • 26. [Introduce mandatory notification for all invasive Staphylococcus aureus infections!].
    Jacobsson G
    Lakartidningen; 2010 Apr 28-May 4; 107(17):1128-9. PubMed ID: 20518377
    [No Abstract]   [Full Text] [Related]  

  • 27. MRSA-what is it?
    Shoop NM
    Gastroenterol Nurs; 1991; 13(3):169-71. PubMed ID: 2004123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cultures, bundles, and other options for MRSA control.
    ECRI Insitute
    Healthc Hazard Manage Monit; 2007 Jul; 20(11):1-10. PubMed ID: 17619466
    [No Abstract]   [Full Text] [Related]  

  • 29. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.
    Aldeyab MA; Monnet DL; López-Lozano JM; Hughes CM; Scott MG; Kearney MP; Magee FA; McElnay JC
    J Antimicrob Chemother; 2008 Sep; 62(3):593-600. PubMed ID: 18467307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
    Hota B
    Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germ warfare. MRSA has infiltrated one in four health care facilities. How can you keep it at bay?
    Warden J
    Contemp Longterm Care; 1997 Aug; 20(8):62-4, 66, 68. PubMed ID: 10170023
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical epidemiology of an outbreak of nosocomial infections by Staphylococcus aureus resistant to methicillin and aminoglucosides: efficacy of the measures of control].
    Parras F; Coello R
    Med Clin (Barc); 1993 Sep; 101(9):359. PubMed ID: 8412405
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hospital infection with methicillin-resistant Staphylococcus aureus (MRSA)].
    Yoshida J; Yoshida J; Ishimaru T; Iga H; Koyanagi N; Kono K
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():69-74. PubMed ID: 12717948
    [No Abstract]   [Full Text] [Related]  

  • 35. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimising patient isolation due to methicllin-resistant Staphylococcus aureus].
    Kluytmans JA; van den Broek PJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(15):794-6. PubMed ID: 15850268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bad bugs. What you need to know about VRE/MRSA.
    Lejeune JR; Berkowitz DM
    JEMS; 2000 Dec; 25(12):56-61; quiz 62. PubMed ID: 11138384
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes.
    Suetens C; Niclaes L; Jans B; Verhaegen J; Schuermans A; Van Eldere J; Vandenbroucke JP; Buntinx F
    Age Ageing; 2007 May; 36(3):327-30. PubMed ID: 17395619
    [No Abstract]   [Full Text] [Related]  

  • 39. [Contribution to guidelines for care of MRSA-positive patients].
    Benes J; Unzeitigová M
    Klin Mikrobiol Infekc Lek; 2006 Aug; 12(4):169-72. PubMed ID: 17019799
    [No Abstract]   [Full Text] [Related]  

  • 40. CDC: hospitals "need to do more" to control MRSA. AHRQ report disheartening.
    Hosp Peer Rev; 2008 Jan; 33(1):5-6, 11. PubMed ID: 18402275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.